Hiroki Hagimoto
Papers
7
Total Citations
34
H-Index
4
About
Dr. Hiroki Hagimoto is a pioneering urologic surgeon and researcher whose work centers on advancing robot-assisted surgical techniques for prostate and kidney cancers. His major contributions lie in optimizing perioperative outcomes, particularly through studies on anticoagulant management during robot-assisted radical prostatectomy (RARP) and comparing robot-assisted versus laparoscopic partial nephrectomy with cortical renorrhaphy omission. Dr. Hagimoto’s research on the impact of renal sinus protrusions on achieving "trifecta" outcomes in partial nephrectomy has refined patient selection and surgical planning. His investigations into neoadjuvant chemohormonal therapy for very high-risk prostate cancer, including dose compliance of estramustine phosphate, offer critical insights into biochemical recurrence prevention. Notably, he has also explored neurovascular bundle preservation’s effect on recurrence in high-risk prostate cancer and innovative approaches like transvesical bladder diverticulectomy during RARP. With over 30 citations across his most-cited works, Dr. Hagimoto’s research consistently pushes the boundaries of minimally invasive urologic oncology, blending technical innovation with rigorous outcome analysis to improve patient care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7